Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels

M. G. Mainwaring, L. M. Rimsza, S. F. Chen, S. P. Gomez, F. W. Weeks, V. Reddy, J. Lynch, W. S. May, S. Kahn, J. Moreb, H. Leather, R. Braylan, T. C. Rowe, K. J. Finiewicz, J. R. Wingard

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment of refractory acute leukemia with timed sequential chemotherapy using topotecan followed by etoposide + mitoxantrone (T-EM) and correlation with topoisomerase II levels'. Together they form a unique fingerprint.

Medicine & Life Sciences